Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 2-WEEK, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL-GROUP, PHASE 2, MULTICENTER STUDY OF PF-04136309 IN SUBJECTS WITH OSTEOARTHRITIC PAIN OF THE KNEE

NCT00689273 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00689273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00689273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 2-WEEK, RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PARALLEL-GROUP, PHASE 2, MULTICENTER STUDY OF PF-04136309 IN SUBJECTS WITH OSTEOARTHRITIC PAIN OF THE KNEE
Lead sponsor
Pfizer
Phase
Phase 2
Overall status
Completed
Start date
August 5, 2008
Completion date
November 27, 2008
Enrollment
159 (actual)
Sites
22

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis, knee